GlassScriptPhysician profile
Elliott Yodh
NPI 1497518724
$831.25
in general payments reported to CMS, 2019-2025
12 companies · $831 in 2025
The $831 reported for 2025 was more than what 77% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $831.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $831.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $831.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spinal Simplicity, LLC | $198.38 | 2025 | Ha Minuteman G3-R |
| Averitas Pharma INC. | $197.13 | 2025 | Qutenza |
| Alkermes, INC. | $139.70 | 2025 | Vivitrol |
| Collegium Pharmaceutical, INC. | $61.94 | 2025 | Xtampza |
| Boston Scientific Corporation | $54.50 | 2025 | Wavewriter Alpha Prime 16 |
| Valinor Pharma, LLC | $44.04 | 2025 | Movantik |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $42.88 | 2025 | Relistor |
| Azurity Pharmaceuticals, INC. | $27.99 | 2025 | Horizant |
| Vertex Pharmaceuticals Incorporated | $19.88 | 2025 | Journavx |
| Ibsa Pharma INC. | $17.48 | 2025 | Flector, Tirosint, Licart |
| Axsome Therapeutics, INC. | $15.07 | 2025 | Symbravo |
| Foundation Fusion Solutions, LLC | $12.26 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elliott Yodh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.